The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities
Crosscope and KFBIO join forces to lead digital transformation for pathology in India and emerging markets
The medicine is now approved for eight indications across five different types of cancer in China.
Labetalol hydrochloride injection USP is indicated for the control of blood pressure in severe hypertension.
The lab will offer over 4,000 clinical tests and profiles and can conduct over 20,000 sample tests per month.
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
It is the first-ever approval in India for the treatment of Female Pattern Hair Loss (FPHL) and will be available only on prescription by a dermatologist
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
In March 2016, Dr. Reddy’s had acquired the exclusive global rights (excluding Japan and Asia) to the investigational anti-cancer agent E7777 from Eisai Co.
Subscribe To Our Newsletter & Stay Updated
